Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – PRNewswire
/PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI)…
SILVER SPRING, Md., April 9, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
“Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with…
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News10 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now